Deciphera Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:DCPH Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
16 Feb 24	SellUS$35,405	Jama Pitman	Individual	2,267	US$15.62
16 Feb 24	SellUS$35,405	Daniel Martin	Individual	2,267	US$15.62
16 Feb 24	SellUS$47,009	Thomas Kelly	Individual	3,010	US$15.62
16 Feb 24	SellUS$40,840	Matthew Sherman	Individual	2,615	US$15.62
16 Jan 24	SellUS$23,499	Daniel Martin	Individual	1,624	US$14.47
16 Jan 24	SellUS$35,234	Thomas Kelly	Individual	2,435	US$14.47
16 Jan 24	SellUS$23,499	Jama Pitman	Individual	1,624	US$14.47
16 Jan 24	SellUS$35,234	Matthew Sherman	Individual	2,435	US$14.47

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of DCPH?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	1,597	0.00185%
Individual Insiders	615,193	0.711%
General Public	1,905,923	2.2%
Hedge Funds	16,323,913	18.9%
VC/PE Firms	23,107,844	26.7%
Institutions	44,521,502	51.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.1%.

Top Shareholders

Top 25 shareholders own 82.75% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
26.7%	Brightstar Associates, LLC	23,107,844	US$591.3m	0.21%	no data
6.93%	BlackRock, Inc.	5,994,276	US$153.4m	0.3%	no data
6.82%	Armistice Capital LLC	5,900,000	US$151.0m	13.5%	4.18%
6.12%	Redmile Group, LLC	5,296,643	US$135.5m	10.3%	5.46%
5.93%	Deerfield Management Company, L.P. Series C	5,127,270	US$131.2m	-11.4%	2.38%
5.28%	The Vanguard Group, Inc.	4,565,044	US$116.8m	3.71%	no data
3.58%	State Street Global Advisors, Inc.	3,098,806	US$79.3m	25.4%	no data
2.16%	Emerald Advisers, LLC	1,869,273	US$47.8m	56.1%	1.08%
1.86%	Dimensional Fund Advisors LP	1,606,132	US$41.1m	2.85%	0.01%
1.73%	Polar Capital Holdings Plc	1,500,000	US$38.4m	-18.9%	0.15%
1.69%	Goldman Sachs Group, Investment Banking and Securities Investments	1,463,417	US$37.4m	-19.5%	0.02%
1.68%	Frazier Life Sciences Management, LP	1,455,837	US$37.3m	42.5%	1.79%
1.65%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	1,422,770	US$36.4m	0.89%	0.01%
1.53%	Morgan Stanley, Investment Banking and Brokerage Investments	1,321,377	US$33.8m	-37%	no data
1.45%	Geode Capital Management, LLC	1,254,317	US$32.1m	2.7%	no data
0.95%	Jefferies Financial Group Inc.,Asset Management Arm	822,515	US$21.0m	-10.4%	0.51%
0.94%	Assenagon Asset Management S.A.	809,923	US$20.7m	0%	0.04%
0.92%	Millennium Management LLC	797,100	US$20.4m	22.2%	0.02%
0.84%	Parkman Healthcare Partners LLC	729,230	US$18.7m	30%	2.44%
0.7%	Braidwell LP	609,643	US$15.6m	-47.9%	0.96%
0.69%	Tang Capital Management, LLC	600,000	US$15.4m	0%	1.86%
0.67%	New Leaf Venture Partners, LLC	576,975	US$14.8m	0%	15.11%
0.65%	UBS Asset Management AG	564,978	US$14.5m	7.34%	no data
0.61%	Charles Schwab Investment Management, Inc.	531,475	US$13.6m	3.14%	no data
0.61%	Renaissance Technologies LLC	530,200	US$13.6m	21.2%	0.02%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/06/11 08:26
End of Day Share Price	2024/06/11 00:00
Earnings	2024/03/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Deciphera Pharmaceuticals, Inc. is covered by 17 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Madhu Kumar	B. Riley Securities, Inc.
Arlinda Lee	Canaccord Genuity
Charles Duncan	Cantor Fitzgerald & Co.